Uppsala Monitoring Centre
Damon Fahimi has a diverse work experience that spans over several companies and roles. Damon began their career as a Customer Support Representative at Apoteket AB from 2005 to 2009. Damon then worked as a Shop Assistant at Vårdapoteket i Norden AB from 2010 to 2012. Damon also worked as a Pharmacist at DocMorris from 2012 to 2013. Damon then transitioned to a Consulting coding specialist role at Uppsala Monitoring Centre through Proffice - Life Science from 2012 to 2014. Within Uppsala Monitoring Centre, they held various roles including Terminology Specialist from 2014 to 2016, Product Specialist from 2016 to 2018, Outreach Manager from 2018 to 2019, Product & Outreach Manager from 2019 to 2021, Senior Outreach Manager from 2021 to 2022, and is currently the Head of Outreach since June 2022. Damon has been responsible for managing outreach teams, raising awareness of products and services, collaborating with external stakeholders, and supporting user communities. Damon has also been involved in life cycle management, product development, and providing training and support to users in the pharmaceutical industry.
Damon Fahimi began their education in 2003 at Katedralskolan in Uppsala, where they pursued a natural sciences' program until 2006. Damon then went on to Uppsala University from 2006 to 2007, where they studied music theory and musicology. In 2007, Damon Fahimi enrolled in Uppsala University once again, this time pursuing a Master of Science in Pharmacy, which they successfully completed in 2012. During their MSc in Pharmacy, they also attended the University of Bath in 2011 to take specific courses related to their degree.
This person is not in any teams
Uppsala Monitoring Centre
Uppsala Monitoring Centre is an independent, non-profit foundation and a centre for international service and scientific research in the field of pharmacovigilance. We advance the safety of patients by exploring and understanding the risks and benefits of medicines, with the ultimate aim of helping patients and physicians make wise therapeutic decisions. For more than 40 years, we have provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring, expanding the global pharmacovigilance network to reach more than 95% of the world’s population. We create partnerships that bring together resources, expertise, and a shared vision of patient safety. Today, we continue to build a global drug safety culture by supporting and engaging all pharmacovigilance stakeholders, from national centres to regulators, academia and the pharma industry.